Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Group 1 - Sight Sciences, Inc. reported a quarterly loss of $0.23 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.20, and compared to a loss of $0.22 per share a year ago, indicating an earnings surprise of -15% [1] - The company posted revenues of $19.07 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.50%, and showing an increase from $18.75 million in the same quarter last year [2] - Sight Sciences has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates three times during the same period [2] Group 2 - The stock has underperformed, losing about 32.1% since the beginning of the year, while the S&P 500 has declined by only -1.8% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.23 on revenues of $19.11 million, and for the current fiscal year, it is -$0.91 on revenues of $82.27 million [7] - The Zacks Industry Rank for Medical - Instruments is currently in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]